IBDEI063 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2638,1,5,0)
 ;;=5^Mets to Lymph Nodes,Axillary Or Brachial
 ;;^UTILITY(U,$J,358.3,2638,2)
 ;;=^267317
 ;;^UTILITY(U,$J,358.3,2639,0)
 ;;=196.0^^27^240^73
 ;;^UTILITY(U,$J,358.3,2639,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2639,1,4,0)
 ;;=4^196.0
 ;;^UTILITY(U,$J,358.3,2639,1,5,0)
 ;;=5^Mets to Lymph Nodes,Cervical
 ;;^UTILITY(U,$J,358.3,2639,2)
 ;;=Lymph Nodes^267314
 ;;^UTILITY(U,$J,358.3,2640,0)
 ;;=196.1^^27^240^74
 ;;^UTILITY(U,$J,358.3,2640,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2640,1,4,0)
 ;;=4^196.1
 ;;^UTILITY(U,$J,358.3,2640,1,5,0)
 ;;=5^Mets to Lymph Nodes,Mediastinal 
 ;;^UTILITY(U,$J,358.3,2640,2)
 ;;=Lymph Nodes^267315
 ;;^UTILITY(U,$J,358.3,2641,0)
 ;;=196.8^^27^240^75
 ;;^UTILITY(U,$J,358.3,2641,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2641,1,4,0)
 ;;=4^196.8
 ;;^UTILITY(U,$J,358.3,2641,1,5,0)
 ;;=5^Mets to Lymph Nodes,Multiple Sites
 ;;^UTILITY(U,$J,358.3,2641,2)
 ;;=^267320
 ;;^UTILITY(U,$J,358.3,2642,0)
 ;;=V10.51^^27^240^33
 ;;^UTILITY(U,$J,358.3,2642,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2642,1,4,0)
 ;;=4^V10.51
 ;;^UTILITY(U,$J,358.3,2642,1,5,0)
 ;;=5^H/O Bladder Cancer
 ;;^UTILITY(U,$J,358.3,2642,2)
 ;;=^295228
 ;;^UTILITY(U,$J,358.3,2643,0)
 ;;=V10.3^^27^240^34
 ;;^UTILITY(U,$J,358.3,2643,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2643,1,4,0)
 ;;=4^V10.3
 ;;^UTILITY(U,$J,358.3,2643,1,5,0)
 ;;=5^H/O Breast Cancer
 ;;^UTILITY(U,$J,358.3,2643,2)
 ;;=^295217
 ;;^UTILITY(U,$J,358.3,2644,0)
 ;;=V10.41^^27^240^35
 ;;^UTILITY(U,$J,358.3,2644,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2644,1,4,0)
 ;;=4^V10.41
 ;;^UTILITY(U,$J,358.3,2644,1,5,0)
 ;;=5^H/O Cervical Cancer
 ;;^UTILITY(U,$J,358.3,2644,2)
 ;;=^295219
 ;;^UTILITY(U,$J,358.3,2645,0)
 ;;=V10.05^^27^240^36
 ;;^UTILITY(U,$J,358.3,2645,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2645,1,4,0)
 ;;=4^V10.05
 ;;^UTILITY(U,$J,358.3,2645,1,5,0)
 ;;=5^H/O Colon Cancer
 ;;^UTILITY(U,$J,358.3,2645,2)
 ;;=H/O Colon Cancer^295207
 ;;^UTILITY(U,$J,358.3,2646,0)
 ;;=V10.03^^27^240^37
 ;;^UTILITY(U,$J,358.3,2646,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2646,1,4,0)
 ;;=4^V10.03
 ;;^UTILITY(U,$J,358.3,2646,1,5,0)
 ;;=5^H/O Esophageal Cancer
 ;;^UTILITY(U,$J,358.3,2646,2)
 ;;=^295205
 ;;^UTILITY(U,$J,358.3,2647,0)
 ;;=V10.60^^27^240^39
 ;;^UTILITY(U,$J,358.3,2647,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2647,1,4,0)
 ;;=4^V10.60
 ;;^UTILITY(U,$J,358.3,2647,1,5,0)
 ;;=5^H/O Leukemia
 ;;^UTILITY(U,$J,358.3,2647,2)
 ;;=H/O Leukemia^295231
 ;;^UTILITY(U,$J,358.3,2648,0)
 ;;=V10.11^^27^240^40
 ;;^UTILITY(U,$J,358.3,2648,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2648,1,4,0)
 ;;=4^V10.11
 ;;^UTILITY(U,$J,358.3,2648,1,5,0)
 ;;=5^H/O Lung Cancer
 ;;^UTILITY(U,$J,358.3,2648,2)
 ;;=H/O Lung Cancer^295211
 ;;^UTILITY(U,$J,358.3,2649,0)
 ;;=V10.79^^27^240^41
 ;;^UTILITY(U,$J,358.3,2649,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2649,1,4,0)
 ;;=4^V10.79
 ;;^UTILITY(U,$J,358.3,2649,1,5,0)
 ;;=5^H/O Lymphoma
 ;;^UTILITY(U,$J,358.3,2649,2)
 ;;=H/O Lymphoma^295238
 ;;^UTILITY(U,$J,358.3,2650,0)
 ;;=V10.82^^27^240^43
 ;;^UTILITY(U,$J,358.3,2650,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2650,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,2650,1,5,0)
 ;;=5^H/O Malig Melanoma Of Skin
 ;;^UTILITY(U,$J,358.3,2650,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,2651,0)
 ;;=V10.02^^27^240^45
 ;;^UTILITY(U,$J,358.3,2651,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2651,1,4,0)
 ;;=4^V10.02
 ;;^UTILITY(U,$J,358.3,2651,1,5,0)
 ;;=5^H/O Oral Cavity/Pharynx Cancer
 ;;^UTILITY(U,$J,358.3,2651,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,2652,0)
 ;;=V10.43^^27^240^46
